| rs2305884 |
chr16 |
30970741 |
0.000014 |
G |
A |
Psoriasis |
SETD1A |
intron |
19169255
|
| rs2305884 |
chr16 |
30970741 |
2.47e-42 |
G |
A |
Acenocoumarol maintenance dosage |
SETD1A |
intron |
19578179
|
| rs2305884 |
chr16 |
30970741 |
0.00000047 |
G |
A |
Red blood cell traits |
SETD1A |
intron |
23222517
|
| rs1870293 |
chr16 |
30970941 |
0.000000213 |
T |
C |
Red blood cell traits |
SETD1A |
intron |
23222517
|
| rs2054213 |
chr16 |
30971810 |
0.0000000437 |
A |
G |
Red blood cell traits |
SETD1A |
intron |
23222517
|
| rs11150601 |
chr16 |
30977799 |
0.000000221 |
G |
A |
Red blood cell traits |
SETD1A |
intron |
23222517
|
| rs897986 |
chr16 |
30980902 |
0.000014 |
T |
C |
Psoriasis |
SETD1A |
intron |
19169255
|
| rs897986 |
chr16 |
30980902 |
1.43e-43 |
T |
C |
Acenocoumarol maintenance dosage |
SETD1A |
intron |
19578179
|
| rs897986 |
chr16 |
30980902 |
0.000000471 |
T |
C |
Red blood cell traits |
SETD1A |
intron |
23222517
|
| rs4889603 |
chr16 |
30982225 |
6.75e-16 |
A |
G |
Warfarin responsiveness (phenprocoumon) |
SETD1A |
intron |
21063236
|
| rs4889603 |
chr16 |
30982225 |
0.0000413 |
A |
G |
Parkinson's disease |
SETD1A |
intron |
22451204
|
| rs4889525 |
chr16 |
30989858 |
0.00000015 |
T |
C |
Red blood cell traits |
SETD1A |
intron |
23222517
|
| rs6950 |
chr16 |
30995669 |
0.0000000428 |
T |
A,C,G |
Red blood cell traits |
SETD1A |
UTR-3 |
23222517
|